DE3584120D1 - Tetrapyrrolverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. - Google Patents
Tetrapyrrolverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.Info
- Publication number
- DE3584120D1 DE3584120D1 DE8585108981T DE3584120T DE3584120D1 DE 3584120 D1 DE3584120 D1 DE 3584120D1 DE 8585108981 T DE8585108981 T DE 8585108981T DE 3584120 T DE3584120 T DE 3584120T DE 3584120 D1 DE3584120 D1 DE 3584120D1
- Authority
- DE
- Germany
- Prior art keywords
- compounds
- tetrapyrrol
- production
- tetrapyrrole
- pharmaceutical preparations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polyamides (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/631,925 US4675338A (en) | 1984-07-18 | 1984-07-18 | Tetrapyrrole therapeutic agents |
US06/728,784 US4693885A (en) | 1984-07-18 | 1985-04-30 | Tetrapyrrole therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3584120D1 true DE3584120D1 (de) | 1991-10-24 |
Family
ID=27091504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8585108981T Expired - Lifetime DE3584120D1 (de) | 1984-07-18 | 1985-07-18 | Tetrapyrrolverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. |
Country Status (9)
Country | Link |
---|---|
US (1) | US4693885A (de) |
EP (1) | EP0168831B1 (de) |
AT (1) | ATE67505T1 (de) |
AU (1) | AU592058B2 (de) |
CA (1) | CA1264740A (de) |
DE (1) | DE3584120D1 (de) |
DK (1) | DK167769B1 (de) |
HK (1) | HK90894A (de) |
NO (1) | NO169291C (de) |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5087622A (en) * | 1982-03-30 | 1992-02-11 | The Rockefeller University | Method of controlling T3 and T4 levels in vivo with cobalt porphyrins |
US4675338A (en) * | 1984-07-18 | 1987-06-23 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
US4977177A (en) * | 1985-04-30 | 1990-12-11 | Nippon Petrochemicals Company, Ltd. | Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents |
US4656186A (en) * | 1985-04-30 | 1987-04-07 | Nippon Petrochemicals Co., Ltd. | Tetrapyrrole therapeutic agents |
US5066274A (en) * | 1985-04-30 | 1991-11-19 | Nippon Petrochemicals Company, Ltd. | Tetrapyrrole therapeutic agents |
JPS63501219A (ja) * | 1986-02-21 | 1988-05-12 | ザ ロツクフエラ− ユニバ−シテイ | 内分泌系ホルモン生成抑制用非経口投与治療組成物および方法 |
US5084475A (en) * | 1986-02-21 | 1992-01-28 | The Rockefeller University | Methods for suppressing the endocrine system |
US5063223A (en) * | 1986-02-21 | 1991-11-05 | The Rockefeller University | Method of controlling androstene levels in vivo with cobalt porphyrins |
US5004811A (en) * | 1987-12-24 | 1991-04-02 | Nippon Petrochemicals Company, Ltd. | Tetrapyrrole aminocarboxylic acids |
US5015478A (en) * | 1988-08-15 | 1991-05-14 | Cytopharm, Inc. | Porphycene anti-cancer agents and treatment methods |
US4913907A (en) * | 1988-08-15 | 1990-04-03 | Cytopharm, Inc. | Porphycene anti-cancer agents and treatment methods |
US5028594A (en) * | 1988-12-27 | 1991-07-02 | Naxcor | Use of photodynamic compositions for cytotoxic effects |
US4997828A (en) * | 1989-02-14 | 1991-03-05 | The Rockefeller University | Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin |
US4959356A (en) * | 1989-05-26 | 1990-09-25 | The United States Of America As Represented By The United States Department Of Energy | Porphyrins for boron neutron capture therapy |
US4997639A (en) * | 1989-11-27 | 1991-03-05 | Nippon Petrochemicals Company, Limited | Method for detecting cholesterol deposited in bodies of mammals |
DE4016299A1 (de) * | 1990-05-21 | 1991-11-28 | Basf Ag | Chlorinderivate |
CA2093361C (en) * | 1990-10-05 | 2002-04-23 | Michel Ringuet | Porphyrin derivative |
JP3154742B2 (ja) * | 1991-04-30 | 2001-04-09 | 日本石油化学株式会社 | 哺乳類の動脈硬化症治療剤 |
US5330741A (en) * | 1992-02-24 | 1994-07-19 | The Regents Of The University Of California | Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors |
JP3565442B2 (ja) * | 1993-04-22 | 2004-09-15 | 新日本石油化学株式会社 | 哺乳類の関節炎の診断剤および/または治療剤 |
US5669916A (en) * | 1994-09-28 | 1997-09-23 | The General Hospital Corporation | Method of hair removal |
WO2000000204A1 (en) | 1997-02-14 | 2000-01-06 | Miravant Pharmaceuticals, Inc. | Indium photosensitizers for pdt |
US20020173523A1 (en) * | 1997-08-05 | 2002-11-21 | Yukari Kuroiwa | Immunosuppression by photochemotherapy |
ATE255583T1 (de) * | 1998-07-10 | 2003-12-15 | Meiji Seika Kaisha | Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen |
US6511971B1 (en) | 1998-10-13 | 2003-01-28 | Brown University Research Foundation | Substituted perhalogenated phthalocyanines |
US6454789B1 (en) * | 1999-01-15 | 2002-09-24 | Light Science Corporation | Patient portable device for photodynamic therapy |
WO2000041726A2 (en) | 1999-01-15 | 2000-07-20 | Light Sciences Corporation | Noninvasive vascular therapy |
US6602274B1 (en) | 1999-01-15 | 2003-08-05 | Light Sciences Corporation | Targeted transcutaneous cancer therapy |
US20030114434A1 (en) * | 1999-08-31 | 2003-06-19 | James Chen | Extended duration light activated cancer therapy |
US7897140B2 (en) | 1999-12-23 | 2011-03-01 | Health Research, Inc. | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents |
JP2003012547A (ja) * | 2001-06-27 | 2003-01-15 | Meiji Seika Kaisha Ltd | インスリン依存性糖尿病の診断剤および治療剤 |
AU2003248747A1 (en) | 2002-06-27 | 2004-01-19 | Health Research, Inc. | Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
EP1606291A2 (de) | 2002-07-02 | 2005-12-21 | Health Research, Inc. | Effiziente synthese von pyropheophorbid-a und seiner derivate |
IL152900A0 (en) * | 2002-11-17 | 2003-06-24 | Yeda Res & Dev | Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses |
US10376711B2 (en) | 2003-03-14 | 2019-08-13 | Light Sciences Oncology Inc. | Light generating guide wire for intravascular use |
CN2885311Y (zh) | 2006-01-18 | 2007-04-04 | 郑成福 | 经尿道光动力疗法前列腺治疗仪 |
US20050085455A1 (en) * | 2003-10-16 | 2005-04-21 | Light Sciences Corporation | Photodynamic therapy for local adipocyte reduction |
US20050101582A1 (en) | 2003-11-12 | 2005-05-12 | Allergan, Inc. | Compositions and methods for treating a posterior segment of an eye |
US20070224278A1 (en) | 2003-11-12 | 2007-09-27 | Lyons Robert T | Low immunogenicity corticosteroid compositions |
AU2005209201B2 (en) | 2004-01-20 | 2010-06-03 | Allergan, Inc. | Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
US20050244471A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Estradiol derivative and estratopone containing sustained release intraocular implants and related methods |
WO2005110374A1 (en) * | 2004-04-30 | 2005-11-24 | Allergan, Inc. | Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component |
US20050244478A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Anti-excititoxic sustained release intraocular implants and related methods |
US8512738B2 (en) | 2004-04-30 | 2013-08-20 | Allergan, Inc. | Biodegradable intravitreal tyrosine kinase implants |
US20070059336A1 (en) * | 2004-04-30 | 2007-03-15 | Allergan, Inc. | Anti-angiogenic sustained release intraocular implants and related methods |
US20050244465A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Drug delivery systems and methods for treatment of an eye |
US8119154B2 (en) | 2004-04-30 | 2012-02-21 | Allergan, Inc. | Sustained release intraocular implants and related methods |
US8722097B2 (en) | 2004-04-30 | 2014-05-13 | Allergan, Inc. | Oil-in-water method for making polymeric implants containing a hypotensive lipid |
US20050244458A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular neuropathies |
US9498457B2 (en) | 2004-04-30 | 2016-11-22 | Allergan, Inc. | Hypotensive prostamide-containing biodegradable intraocular implants and related implants |
US8591885B2 (en) * | 2004-04-30 | 2013-11-26 | Allergan, Inc. | Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems |
US20050244500A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Intravitreal implants in conjuction with photodynamic therapy to improve vision |
US8673341B2 (en) | 2004-04-30 | 2014-03-18 | Allergan, Inc. | Intraocular pressure reduction with intracameral bimatoprost implants |
US20050244462A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Devices and methods for treating a mammalian eye |
US8455656B2 (en) | 2004-04-30 | 2013-06-04 | Allergan, Inc. | Kinase inhibitors |
US20050244461A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Controlled release drug delivery systems and methods for treatment of an eye |
US20050244463A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular vasculopathies |
US8147865B2 (en) | 2004-04-30 | 2012-04-03 | Allergan, Inc. | Steroid-containing sustained release intraocular implants and related methods |
US7799336B2 (en) * | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
US7993634B2 (en) | 2004-04-30 | 2011-08-09 | Allergan, Inc. | Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods |
US8425929B2 (en) | 2004-04-30 | 2013-04-23 | Allergan, Inc. | Sustained release intraocular implants and methods for preventing retinal dysfunction |
US7771742B2 (en) | 2004-04-30 | 2010-08-10 | Allergan, Inc. | Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods |
WO2007103427A2 (en) * | 2006-03-06 | 2007-09-13 | Wang Xiang H | Medical use of bilirubin and its structural analogues |
CN101490057B (zh) | 2006-06-30 | 2013-02-27 | 光子科学肿瘤研究公司 | 制造光活性剂的组合物和方法 |
US8969415B2 (en) | 2006-12-01 | 2015-03-03 | Allergan, Inc. | Intraocular drug delivery systems |
US7911053B2 (en) * | 2007-04-19 | 2011-03-22 | Marvell World Trade Ltd. | Semiconductor packaging with internal wiring bus |
US8697610B2 (en) * | 2007-05-11 | 2014-04-15 | Schlumberger Technology Corporation | Well treatment with complexed metal crosslinkers |
US8853135B2 (en) * | 2008-05-07 | 2014-10-07 | Schlumberger Technology Corporation | Method for treating wellbore in a subterranean formation with high density brines and complexed metal crosslinkers |
KR101769637B1 (ko) | 2009-11-09 | 2017-08-18 | 알러간, 인코포레이티드 | 모발 성장을 촉진하기 위한 조성물 및 방법 |
WO2014071138A1 (en) | 2012-11-02 | 2014-05-08 | Lewis Thomas J | Disease detection and treatment through activation of compounds using external energy |
BR112015019546A2 (pt) | 2013-02-15 | 2017-07-18 | Allergan Inc | implante de distribuição de drogas prolongado |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4393071A (en) * | 1975-03-17 | 1983-07-12 | Naoharu Fujii | Method of treating gastric, mammary, lung and uterus tumors |
JPS53109929A (en) * | 1977-03-04 | 1978-09-26 | Nippon Oil Co Ltd | Medicin for malignant tumor |
ATE53204T1 (de) * | 1982-09-27 | 1990-06-15 | Photofrin Medical Inc | Gereinigte hematoporphyrinabkoemmlinge fuer diagnose und tumorbehandlung sowie verfahren. |
-
1985
- 1985-04-30 US US06/728,784 patent/US4693885A/en not_active Expired - Lifetime
- 1985-07-18 AT AT85108981T patent/ATE67505T1/de not_active IP Right Cessation
- 1985-07-18 NO NO852872A patent/NO169291C/no not_active IP Right Cessation
- 1985-07-18 AU AU45159/85A patent/AU592058B2/en not_active Expired
- 1985-07-18 DK DK326885A patent/DK167769B1/da not_active IP Right Cessation
- 1985-07-18 EP EP85108981A patent/EP0168831B1/de not_active Expired - Lifetime
- 1985-07-18 CA CA000487041A patent/CA1264740A/en not_active Expired - Lifetime
- 1985-07-18 DE DE8585108981T patent/DE3584120D1/de not_active Expired - Lifetime
-
1994
- 1994-09-01 HK HK90894A patent/HK90894A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0168831A3 (en) | 1988-05-04 |
NO852872L (no) | 1986-01-20 |
AU4515985A (en) | 1986-01-23 |
EP0168831B1 (de) | 1991-09-18 |
NO169291C (no) | 1992-06-03 |
AU592058B2 (en) | 1990-01-04 |
HK90894A (en) | 1994-09-09 |
EP0168831A2 (de) | 1986-01-22 |
CA1264740C (en) | 1990-01-23 |
NO169291B (no) | 1992-02-24 |
CA1264740A (en) | 1990-01-23 |
DK167769B1 (da) | 1993-12-13 |
DK326885A (da) | 1986-01-19 |
ATE67505T1 (de) | 1991-10-15 |
DK326885D0 (da) | 1985-07-18 |
US4693885A (en) | 1987-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3584120D1 (de) | Tetrapyrrolverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
MY110734A (en) | Improvements in or relating to dioic acids. | |
ATE94547T1 (de) | Pharmazeutische zubereitung enthaltend eine tetrahydropyrrolverbindung als aktiven bestandteil und verfahren zur herstellung dieser tetrapyrrolverbindung. | |
DE69625906T2 (de) | Dinukleotide zur verwendung in der behandlung von lungenkrankheiten | |
IL133585A0 (en) | Soluble prodrugs of paclitaxel | |
ATE80297T1 (de) | Tetrapyrrolpolyaminomonocarbonsaeuretherapiemittel. | |
EP0221041A3 (de) | Benzimidazolderivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung | |
BR9813373A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente | |
DE69025920D1 (de) | Glykosaminoglykan-modifiertes Protein, Verfahren zu dessen Herstellung und pharmazeutische Zubereitungen, die es enthalten | |
HUT54705A (en) | Process for producing 11 beta-aryl-4-estrenes and pharmaceutical compositions comprising same | |
EP0911331A3 (de) | Substutierte Dibenzoxazepinverbindungen, pharmazeutische Zusammensetzungen, und Anwendungsmethoden | |
ES2010561A6 (es) | Procedimiento para preparar una composicion farmaceutica a base de un analogo de somatostatina. | |
DE3650358D1 (de) | Diphosphonate enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Arthrosis. | |
BE898749A (fr) | Nouveau procede de preparation de formes galeniques utiles notamment en therapeutique, dietetique, cosmetique et diagnostic | |
EP0173664A3 (de) | Biologisch aktive Benzimidazolderivate und Verfahren zu ihrer Herstellung | |
BR9813318A (pt) | Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário | |
DE69521536D1 (de) | Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten | |
ES478967A1 (es) | Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7. | |
DE3777845D1 (de) | Pharmazeutischer stoff fuer die behandlung von myelogener leukaemie. | |
DE2967356D1 (en) | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | |
EP0652755A1 (de) | Therapeutische verwendung von phosphoryl-l-serin-n-acyl-sphingosin. | |
ATE265217T1 (de) | Antikrebs-therapeutische zusammensetzungen die molke-proteinkonzentrat enthalten | |
EP0154886A3 (de) | Carboxyalkyldipeptidderivate, Verfahren zu deren Herstellung, diese enthaltende Mittel und deren Verwendung | |
KR840002006A (ko) | 포스포르아미드 유도체, 그의 제법 및 그것을 함유하는 의약 | |
MX9800686A (es) | Nueva proteina hmw humana mp52s. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |